Login

CEO Fernando Lehner Discusses BVZ Holding AG's 2017 Annual Results: An Interview | Fernando Lehner - CEO of bvz holding ag 00:10:00

Share On Facebook Share On Twitter

Fernando Lehner is the CEO of bvz holding ag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The company's efforts to transition two key therapeutics targeting Alzheimer's disease and psychiatric disorders towards full commercialization|Stephan Jackman,CEO,Alzamend Neuro Inc
00:10:00
Max Boot on the History and Importance of Guerrilla Warfare
00:10:00
Supports entrepreneurs that develops technology solutions|Jennifer Carolan,Co-Founder and General Partner,Reach Capital
00:10:00
Co-CEO Nir Bar Dea Discusses Navigating a Critical Generational Shift at Bridgewater: Insights on Talent, Culture, and Future Business Priorities
00:10:00
Counting Our Blessings: End-of-Year Checklist and Financial Guidance
00:10:00
Interview with Willem Middelkoop on Discovery Investing in Mining
00:10:00
Adtalem CEO Steve Beard on Q4 Earnings, College Enrollment, and Addressing the Healthcare Worker Shortage | Steve Beard , CEO, Adtalem Global Education.
00:10:00
Philippe Brassac Discusses Crédit Agricole's Financial Performance and Economic Outlook | Philippe Brassac , CEO ,  Crédit Agricole SA .
00:10:00
Weijian Shan on the Cultural Revolution and US-China Relations | Weijian Shan, CEO, PAG Group.
00:10:00
Koen Dejonckheere Discusses Gimv's Role in Modern Healthcare | Koen Dejonckheere, CEO, GIMV Corporate.
00:10:00
Resolute: Pioneering Automation in Gold Mining at Syama
00:10:00
Paul Boudre, CEO of Soitec, discusses 5G growth and business at the Singapore Summit.|Paul Boudre, CEO of Soitec

© 2017 - Neuhu+